258 related articles for article (PubMed ID: 30301799)
1. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
[TBL] [Abstract][Full Text] [Related]
2. Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice.
Li HS; Jin J; Liang X; Matatall KA; Ma Y; Zhang H; Ullrich SE; King KY; Sun SC; Watowich SS
Eur J Haematol; 2016 Sep; 97(3):261-70. PubMed ID: 26660446
[TBL] [Abstract][Full Text] [Related]
3. GATA2 mutations in myeloid malignancies: Two zinc fingers in many pies.
Leubolt G; Redondo Monte E; Greif PA
IUBMB Life; 2020 Jan; 72(1):151-158. PubMed ID: 31785092
[TBL] [Abstract][Full Text] [Related]
4. GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.
Katsumura KR; Ong IM; DeVilbiss AW; Sanalkumar R; Bresnick EH
Cell Rep; 2016 Aug; 16(9):2428-41. PubMed ID: 27545880
[TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer.
Soukup AA; Zheng Y; Mehta C; Wu J; Liu P; Cao M; Hofmann I; Zhou Y; Zhang J; Johnson KD; Choi K; Keles S; Bresnick EH
J Clin Invest; 2019 Mar; 129(3):1180-1192. PubMed ID: 30620726
[TBL] [Abstract][Full Text] [Related]
6. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity.
Johnson KD; Hsu AP; Ryu MJ; Wang J; Gao X; Boyer ME; Liu Y; Lee Y; Calvo KR; Keles S; Zhang J; Holland SM; Bresnick EH
J Clin Invest; 2012 Oct; 122(10):3692-704. PubMed ID: 22996659
[TBL] [Abstract][Full Text] [Related]
7. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.
Katsumura KR; Liu P; Kim JA; Mehta C; Bresnick EH
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2317147121. PubMed ID: 38422019
[TBL] [Abstract][Full Text] [Related]
9. GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis.
Katayama S; Suzuki M; Yamaoka A; Keleku-Lukwete N; Katsuoka F; Otsuki A; Kure S; Engel JD; Yamamoto M
Blood; 2017 Aug; 130(7):908-919. PubMed ID: 28630119
[TBL] [Abstract][Full Text] [Related]
10. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.
Tien FM; Hou HA; Tsai CH; Tang JL; Chiu YC; Chen CY; Kuo YY; Tseng MH; Peng YL; Liu MC; Liu CW; Liao XW; Lin LI; Lin CT; Wu SJ; Ko BS; Hsu SC; Huang SY; Yao M; Chou WC; Tien HF
Blood Cancer J; 2018 Aug; 8(9):87. PubMed ID: 30190467
[TBL] [Abstract][Full Text] [Related]
11. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
Greif PA; Dufour A; Konstandin NP; Ksienzyk B; Zellmeier E; Tizazu B; Sturm J; Benthaus T; Herold T; Yaghmaie M; Dörge P; Hopfner KP; Hauser A; Graf A; Krebs S; Blum H; Kakadia PM; Schneider S; Hoster E; Schneider F; Stanulla M; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
Blood; 2012 Jul; 120(2):395-403. PubMed ID: 22649106
[TBL] [Abstract][Full Text] [Related]
12. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program.
Mehta C; Johnson KD; Gao X; Ong IM; Katsumura KR; McIver SC; Ranheim EA; Bresnick EH
Cell Rep; 2017 Sep; 20(12):2966-2979. PubMed ID: 28930689
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia.
Zhang SJ; Ma LY; Huang QH; Li G; Gu BW; Gao XD; Shi JY; Wang YY; Gao L; Cai X; Ren RB; Zhu J; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2076-81. PubMed ID: 18250304
[TBL] [Abstract][Full Text] [Related]
14. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia.
Hahn CN; Chong CE; Carmichael CL; Wilkins EJ; Brautigan PJ; Li XC; Babic M; Lin M; Carmagnac A; Lee YK; Kok CH; Gagliardi L; Friend KL; Ekert PG; Butcher CM; Brown AL; Lewis ID; To LB; Timms AE; Storek J; Moore S; Altree M; Escher R; Bardy PG; Suthers GK; D'Andrea RJ; Horwitz MS; Scott HS
Nat Genet; 2011 Sep; 43(10):1012-7. PubMed ID: 21892162
[TBL] [Abstract][Full Text] [Related]
15. Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes.
Chong CE; Venugopal P; Stokes PH; Lee YK; Brautigan PJ; Yeung DTO; Babic M; Engler GA; Lane SW; Klingler-Hoffmann M; Matthews JM; D'Andrea RJ; Brown AL; Hahn CN; Scott HS
Leukemia; 2018 Jan; 32(1):194-202. PubMed ID: 28642594
[TBL] [Abstract][Full Text] [Related]
16. Mechanism governing a stem cell-generating cis-regulatory element.
Sanalkumar R; Johnson KD; Gao X; Boyer ME; Chang YI; Hewitt KJ; Zhang J; Bresnick EH
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):E1091-100. PubMed ID: 24616499
[TBL] [Abstract][Full Text] [Related]
17. GATA2 +9.5 enhancer: from principles of hematopoiesis to genetic diagnosis in precision medicine.
Soukup AA; Bresnick EH
Curr Opin Hematol; 2020 May; 27(3):163-171. PubMed ID: 32205587
[TBL] [Abstract][Full Text] [Related]
18. C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid Progenitor.
Di Genua C; Valletta S; Buono M; Stoilova B; Sweeney C; Rodriguez-Meira A; Grover A; Drissen R; Meng Y; Beveridge R; Aboukhalil Z; Karamitros D; Belderbos ME; Bystrykh L; Thongjuea S; Vyas P; Nerlov C
Cancer Cell; 2020 May; 37(5):690-704.e8. PubMed ID: 32330454
[TBL] [Abstract][Full Text] [Related]
19. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
[TBL] [Abstract][Full Text] [Related]
20. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
Shimizu R; Yamamoto M
IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]